<DOC>
	<DOC>NCT02563535</DOC>
	<brief_summary>The aim of this study is to evaluate the potential advantage in terms of late lumen loss reduction of Litos drug-eluting balloon vs standard percutaneous transluminal angioplasty in the treatment of below-the-knee disease in patients with critical limb ischemia.</brief_summary>
	<brief_title>Evaluation of the Use of ACOTEC Drug-Eluting Balloon Litos Â® in Below-The-Knee Arteries to Treat Critical Limb Ischemia</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>age&gt;18 years critical limb ischemia (Rutherford class 46) angiographic stenosis&gt;50% or occlusion of at least one tibial vessel of at least 40mm for which an interventional treatment is scheduled need for major amputation known before intervention allergy to Paclitaxel contraindication for combined antiplatelet treatment life expectancy &lt;1 year hypersensitivity or contraindication to one of the study drugs lack of consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>